Ambev S.A. (ABEV) is a Beverages - Alcoholic company in the Consumer Defensive sector, currently trading at $3.14. It has a SharesGrow Score of 63/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of ABEV = $7.97 (+153.8% from the current price, the stock appears undervalued). Analyst consensus target is ABEV = $3 (-6.4% upside).
Valuation: ABEV trades at a trailing Price-to-Earnings (P/E) of 16 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 2.12.
Financials: revenue is $88.2B, +3.6%/yr average growth. Net income is $15.5B, growing at +2.4%/yr. Net profit margin is 17.6% (healthy). Gross margin is 51.4% (+2.1 pp trend).
Balance sheet: total debt is $5.3B against $87.9B equity (Debt-to-Equity (D/E) ratio 0.06, conservative). Current ratio is 0.96 (tight liquidity). Debt-to-assets is 3.6%. Total assets: $148.1B.
Analyst outlook: 2 / 14 analysts rate ABEV as buy (14%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 48/100 (Partial), Growth 45/100 (Partial), Past 100/100 (Pass), Health 67/100 (Partial), Moat 88/100 (Pass), Future 26/100 (Fail), Income 70/100 (Pass).
